Sup-Icu RENal (SIREN)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3350 participants.

Also called NCT02718261

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose other
Phase
Phase 4
Enrolled
  • 3,350 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02718261
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02718261. Randomized; triple masking; primary purpose other. Start 2016-02 (actual); primary completion 2018-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sup-Icu RENal (SIREN)
Acronym
SIREN
Condition
Critical Illness
Condition
End-stage Renal Disease
Condition
Renal Replacement Therapy
Condition
Proton Pump Inhibitor
Intervention (Drug)
Pantoprazole
Intervention (Drug)
Saline 0.9% (matching placebo)
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
Copenhagen University Hospital, Rigshospitalet (class: other)

Record details

Record id
cardio:ct-nct02718261
Content hash
2b28dd8d70bf5580bcc5f6a2ab667a423e37c90aa8e36a2e15378e2d1a26f5bb